Previous studies revealed that during melanoma progression, melanoma cells develop stem-cell like properties associated with the expression of SOX10, EZH2 transcription factors, EMT phenotypic switch regulators TWIST1/ZEB1, and the surface receptor CD172 [20]. Here, TWIST1 is linked to melanoma.